Aurinia PharmaceuticalsvsUnitedHealth

AUPH and UNH stock compared: price, dividend, valuation and results, from SEC filings.

AUPH

Aurinia Pharmaceuticals Inc

$14.89

Value $2.0B

-1.59%
AUPH's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Aurinia Pharmaceuticals (AUPH) has a market value of $2.0B and UnitedHealth (UNH) $300B. Over the last year, with dividends, AUPH moved -3.9% and UNH +8.2%. Dividend yield: AUPH none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AUPH$2.0B

    UNH$300B

    UNH is 152 times AUPH

  • Revenue, 12 months

    AUPH$322M

    UNH$450B

    UNH is 1,398 times AUPH

  • Net income, 12 months

    AUPH$314M

    UNH$15.9B

    UNH is 51 times AUPH

  • Operating margin

    AUPH48.6%

    UNH5.3%

    43.3 points apart

  • ROIC

    AUPH22.2%

    UNH11.3%

    10.9 points apart

  • P/E

    AUPH–

    UNH18.9

  • Dividend yield

    AUPH0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    AUPH-49.8%

    UNH-19.5%

    30.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AUPH-49.8%

UNH-19.5%

5010015020222023202420252026
Returns by period
PeriodAUPHWith dividendsUNHWith dividends
1 year since November 18, 2025-3.9%Price -3.9%+8.2%Price +5.4%
3 years since November 17, 2023+73.1%+20.1% a yearPrice +73.1%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021-49.8%-12.9% a yearPrice -49.8%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016+325.4%+15.6% a yearPrice +325.4%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AUPHAurinia PharmaceuticalsUNHUnitedHealth

Valuation

AUPHUNH
Valuation
Price$14.89$330.48
Market value$2.0B$300B
Enterprise value (EV)$1.5B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B3.02.9
EV/EBIT9.914.5
Free cash flow yield8.9%7.6%

Results and growth

AUPHUNH
Results and growth
Revenue, 12 months$322M$450B
Net income, 12 months$314M$15.9B
Free cash flow, 12 months$177M$22.8B
Earnings per share, 12 months$2.29$17.52
Revenue growth, year on year20.4%11.8%
Revenue growth a year, past+41.4%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

AUPHUNH
Margins and returns on capital
Gross margin90.6%88.3%
Operating margin48.6%5.3%
Net margin97.7%3.5%
ROIC22.2%11.3%
ROE56.4%15.5%

Balance sheet

AUPHUNH
Balance sheet
Cash$487M$28.5B
Total debt$59M$74.3B
Net debt / EBITDA-2.51.6
Interest cover40.4×6.2×

Dividends and buybacks

AUPHUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield5.0%1.8%
Shareholder yield5.0%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AUPH or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Aurinia Pharmaceuticals or UnitedHealth?

By market value, UnitedHealth ($300B) is about 151.5 times Aurinia Pharmaceuticals ($2.0B), at today's prices.

How did AUPH and UNH stock do over the last 10 years?

Since November 21, 2016, AUPH's price moved +325.4% and UNH's +119.7%. With dividends: AUPH +325.4% (+15.6% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, AUPH or UNH?

The dividend yield at today's price is none for Aurinia Pharmaceuticals and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Aurinia Pharmaceuticals or UnitedHealth?

Over the last twelve months, the net margin was 97.7% for Aurinia Pharmaceuticals and 3.5% for UnitedHealth, and the operating margin 48.6% and 5.3%. Revenue was $322M and $450B.

Which is the better investment, Aurinia Pharmaceuticals or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.